Argument sitting
April 2026 oral arguments
Wednesday, April 1, 2026
1Decided June 30, 2026
Whether the Executive Order complies on its face with the Citizenship Clause and with 8 U.S.C. 1401(a), which codifies that Clause?
Monday, April 20, 2026
2Decided June 18, 2026
Can the Rooker-Feldman doctrine, which prevents parties who lose in state courts from challenging injuries caused by state-court judgments, be triggered by a state-court decision that remains subject to further review in state court?
Decided June 4, 2026
May the SEC seek equitable disgorgement under 15 U.S.C. §§ 78u(d)(5) and (d)(7) without showing investors suffered pecuniary harm?
Tuesday, April 21, 2026
1Decided June 4, 2026
Are provisions of the Communications Act of 1934 that govern the Federal Communications Commission’s assessment and enforcement of monetary forfeitures consistent with the Seventh Amendment and Article III?
Wednesday, April 22, 2026
1Decided June 23, 2026
To remove a lawful permanent resident who committed an offense listed in Section 1182(a)(2) and was subsequently paroled into the United States, must the government prove that it possessed clear and convincing evidence of the offense at the time of the lawful permanent resident’s last reentry into the United States?
Monday, April 27, 2026
2Decided June 25, 2026
Does the Federal Insecticide, Fungicide, and Rodenticide Act preempt a label-based failure-to-warn claim where EPA has not required the warning?
Decided June 29, 2026
Did the execution of the geofence warrant violate the Fourth Amendment?
Tuesday, April 28, 2026
1Decided June 23, 2026
Does either the Alien Tort Statute or the Torture Victim Protection Act allow a judicially-implied private right of action for aiding and abetting?
Wednesday, April 29, 2026
1Decided June 4, 2026
1. When a generic drug manufacturer excludes a patented use from its label, can it still be liable for inducing infringement if it calls its product a “generic version” of the brand-name drug and cites publicly available information about the brand-name drug’s sales? 2. Can a patent infringement complaint survive dismissal if it does not allege that the defendant made any statement specifically instructing or encouraging the patented use?